Follow us on Twitter
Stock Index: TSXV:WFG Price: $ 0.04

Waterfront Capital Corporation Appoints Director to the Board

West Vancouver, British Columbia – December 2, 2015 – Waterfront Capital Corporation (the “Company” or “Waterfront Capital”) is pleased to announce that Dr. Mehrun Payravi, Pharm D, MBA, MSc Industrial Pharmacy has been appointed to the Company’s Board of Directors.

Dr. Payravi is a registered pharmacist and holds an MBA from Simon Fraser University. He has worked for a number of Canadian pharmacies, including Shoppers Drug Mart and Rexall, where he most recently held the position of Pharmacy Director for BC responsible for operations of all stores in British Columbia. Dr. Payravi previously worked in Iran where he was head of production for an Iranian drug manufacturing company.

“We are very pleased that Dr. Payravi has joined our Board.  His extensive business background and experience will certainly be advantageous to the Company,” said Douglas Mason, President and CEO of Waterfront Capital Corporation.

About Waterfront Capital and Waterfront Strategic:

Waterfront Capital Corporation (“Waterfront Capital”) and its wholly owned subsidiary, Waterfront Strategic Capital Corporation (“Waterfront Strategic”), offer Business Advisory and Capital Markets services to numerous leading growth companies.

Waterfront Capital’s Business Advisory platform offers a range of products and services designed to increase our clients’ exposure and visibility within a network of Investment Advisors in Canada’s leading independent and bank-owned investment dealers.

Waterfront Strategic offers Capital Markets services by helping raise funds for our corporate clients from accredited retail, institutional and family wealth management clients in Canada and abroad.

Waterfront Strategic is registered as an Exempt Market Dealer in the Provinces of British Columbia, Alberta, Manitoba and Ontario in accordance with National Instrument 31-103 Registration Requirements and Exemptions (“NI 31-103”). Exempt Market Dealers may act as a dealer or underwriter for any securities which are prospectus exempt, and as a dealer for investment funds which are either prospectus qualified or prospectus exempt provided these funds are sold to clients who qualify as exempt purchasers.

For further information, contact Mr. Clive Shallow, Shareholder Communications, at 604-922-2030 or visit the Company’s website at


“Douglas L. Mason”


Douglas L. Mason, Chief Executive Officer

Neither the TSX Venture Exchange nor its Regulation Services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Leave a Reply